in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
APIs Will Drive Growth in Contract Manufacturing
September 25, 2012 | Deepti Ramesh
The manufacture of active pharmaceutical ingredients (APIs) will account for the majority of revenues in the pharmaceutical contract manufacturing industry in the next 10 years, says a recent report by business information provider Visiongain (London). The report predicts that the global market for pharmaceutical contract manufacturing will be worth $47.6 billion in 2012; and between 2011 and 2016, the overall market will grow at a compound annual growth rate of over 6%. API manufacturing formed the largest sector in pharmaceutical contract manufacturing in 2011...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee